Srdjan R. Stankovic - Jan 6, 2022 Form 4 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role
President
Signature
/s/ Austin D. Kim, Attorney-in-Fact
Stock symbol
ACAD
Transactions as of
Jan 6, 2022
Transactions value $
-$44,648
Form type
4
Date filed
1/10/2022, 05:23 PM
Previous filing
Nov 23, 2021
Next filing
Feb 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACAD Common Stock Options Exercise +5.44K +13.11% 47K Jan 6, 2022 Direct F1
transaction ACAD Common Stock Sale -$44.6K -1.94K -4.13% $23.05 45K Jan 6, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACAD Restricted Stock Units Options Exercise $0 -5.44K -33.33% $0.00 10.9K Jan 6, 2022 Common Stock 5.44K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
F3 The restricted stock units vest in four equal annual installments beginning January 6, 2021.